Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to -$1.4 million.

  • Ekso Bionics Holdings' Net Income towards Common Stockholders rose 3146.72% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.4 million, marking a year-over-year decrease of 1126.58%. This contributed to the annual value of -$11.3 million for FY2024, which is 2545.07% up from last year.
  • As of Q3 2025, Ekso Bionics Holdings' Net Income towards Common Stockholders stood at -$1.4 million, which was up 3146.72% from -$4.0 million recorded in Q2 2025.
  • Ekso Bionics Holdings' Net Income towards Common Stockholders' 5-year high stood at -$1.4 million during Q3 2025, with a 5-year trough of -$4.6 million in Q4 2021.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$3.4 million (2024), whereas its average is -$3.4 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first skyrocketed by 4288.42% in 2024, then tumbled by 6721.85% in 2025.
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' Net Income towards Common Stockholders stood at -$4.6 million in 2021, then grew by 1.87% to -$4.5 million in 2022, then increased by 28.61% to -$3.2 million in 2023, then fell by 6.19% to -$3.4 million in 2024, then surged by 58.39% to -$1.4 million in 2025.
  • Its last three reported values are -$1.4 million in Q3 2025, -$4.0 million for Q2 2025, and -$3.5 million during Q1 2025.